Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

Associate

Minji Kim

Goodwin Procter

main

Kim Minji

Goodwin Associate Minji Kim, from Silicon Valley, practices in the Business Law Department with an emphasis on life sciences.

Minji Kim

Areas of Practice

Credentials

Education

JD

M1

BS

Admissions

Bars

Related Content

The Best Lawyers in America 2027 Recognizes Over 200 Goodwin Lawyers Nationwide

Goodwin Advises Dynatrace on $915 Million Agreement to Acquire Arize

Goodwin Advises Most Valuable Promotions on Merger With Professional Fighters League to Create Global Combat Sports Platform

Goodwin Advises MaintainX on Entering into a Definitive Agreement to be Acquired by Autodesk for $3.6 Billion

Goodwin Guides Empower Semiconductor on $1.5 Billion Acquisition by Analog Devices

Goodwin Advises Document Crunch in Acquisition by Trimble

Goodwin Advises Abra on Becoming a Public Company via Business Combination With New Providence Acquisition Corp. III

Goodwin Guides Repertoire Immune Medicines on a Strategic Collaboration with Lilly to Develop Tolerizing Therapies for Autoimmune Diseases for $85 Million Upfront, Up to $1.84 Billion in Milestones, and Potential Tiered Royalties

Life Sciences